Medicines and Healthcare products Regulatory Agency
Consistent with their reviewing trajectory on health and the current pipeline.
Mid-review on life sciences — direction open.
Holding the current health line with no material change.
Mid-review on life sciences; direction not yet settled.
Synthesis is AI-generated; every assertion links to primary sources.